Skip to content

Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Treating Sleep Disruption in Teens With Millisecond Light Exposure During Sleep

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01406691
Enrollment
20
Registered
2011-08-01
Start date
2013-12-31
Completion date
2028-09-30
Last updated
2023-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delayed Sleep Phase Disorder

Keywords

sleep, delayed sleep phase disorder, circadian, teen, adolescent

Brief summary

Delayed Sleep Phase Disorder (DSPD) is a sleep disruption that commonly occurs in teens and manifests as a difficulty in waking up in the morning, going to sleep early enough at night, and daytime disturbances such as depression, fatigue, and restlessness. The purpose of this study is to determine if brief flashes of light, that are scheduled to occur during sleep, are effective in treating DSPD.

Interventions

DEVICEFlashes

one hour of a sequence of light flashes (4000 lux, 3 msec, every 30 seconds); occurs during the hour immediately prior to desired waketime

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
Stanford University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
15 Years to 19 Years
Healthy volunteers
No

Inclusion criteria

* Male or female * Full-time in high school * primary sleep complaint consistent with delayed sleep phase disorder

Exclusion criteria

* sleep only in prone position * currently taking medications specifically for the treatment of a sleep disorder

Design outcomes

Primary

MeasureTime frameDescription
Sleep qualityweekly for four weeksDetermined by questionnaire (Adolescent Sleep Wake Scale)

Secondary

MeasureTime frameDescription
Moodat the begining and end of intervention (4 weeks)Center for Epidemiologic Studies Depression Scale for Children (depressive symptoms) SNAP-IV 26 (ADHD symptoms)

Countries

United States

Contacts

Primary ContactJamie Zeitzer, PhD
jzeitzer@stanford.edu650-493-5000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026